Immunogenicity Assessment and Management

Ensuring the Safety and Efficacy of Biologics

This year's Immunogenicity Stream focuses on the latest science, technologies and strategies to ensure the safety and efficacy of biologics, with a particular focus on novel modalities including cell & gene therapies, bispecifics, immunotherapies and ADCs. Part One provides a practical, comprehensive introduction to immunogenicity via an interactive training seminar. Part Two examines immunogenicity assessment and management including: assay development and validation, clinical relevance, drug and target interference, risk assessment and recent advances with predictive studies and tools.

Programs Include:

May 11-12

Introduction to Immunogenicity

May 12-13

Immunogenicity Assessment and Management

Recommended Short Course:

SC3: Developability of Bispecific Antibodies: Formats and Applications

Instructor: Nimish Gera, PhD, Head, Biologics, Mythic Therapeutics

Keynote Speaker:

Boris Gorovits, PhD, Vice President, In Vitro Pharmacology, Biomarker Discovery and Bioanalysis, Sana Biotechnology